DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
85 hedge funds and large institutions have $20.3M invested in DermTech, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 27 reducing their positions, and 20 closing their positions.
45% more call options, than puts
Call options by funds: $680K | Put options by funds: $469K
14% less funds holding
Funds holding: 99 → 85 (-14)
43% less capital invested
Capital invested by funds: $35.6M → $20.3M (-$15.3M)
44% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 27
65% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Triatomic Management
Palo Alto,
California
|
+$738K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$152K |
| 3 |
Renaissance Technologies
New York
|
+$150K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$95.5K |
| 5 |
BlackRock
New York
|
+$44.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$2.54M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$2.29M |
| 3 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
-$299K |
| 4 |
GWP
Gateway Wealth Partners
Appleton,
Wisconsin
|
-$273K |
| 5 |
CF
Centaurus Financial
Anaheim,
California
|
-$246K |
DMTK Hedge Fund Activity: Q2 2023 in Review
85 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q2 2023, worth a combined $20.3M — down 43% from $35.6M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of DMTK and 7 opened new positions — a net loss of 13 holders — while 27 trimmed existing stakes and 15 added.
The largest buyer was Triatomic Management, adding an estimated $738K. The largest seller was Oracle Investment Management, cutting an estimated $2.54M.
- 85 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q2 2023, down from 99 in Q1 2023.
- Funds reported $20.3M of DermTech, Inc. Common Stock stock for Q2 2023, down 43% quarter-over-quarter.
- 7 funds opened new DermTech, Inc. Common Stock positions in Q2 2023 and 20 closed out, a net change of -13 holders.
- The largest DermTech, Inc. Common Stock buyer in Q2 2023 was Triatomic Management, an estimated $738K added.
- The largest DermTech, Inc. Common Stock seller in Q2 2023 was Oracle Investment Management, an estimated $2.54M sold.
Based on aggregated 13F filings for Q2 2023.